logo

AFIB: Riding the Market Waves of Growth and Decline in 2023

Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The index has shown a price loss of -19.96% this year. Over the last six months, there has been a stronger performance of -77.72%. The price of AFIB leaped by -18.14% during the last 30 days period. For the last 5-days stocks have slided -18.38%.

In terms of market performance, Acutus Medical Inc had a somewhat inconsistent run in. The highest value for the stock in the past year was $1.09 on 05/03/23, while the lowest value was $0.16 on 01/22/24.

52-week price history of AFIB Stock

The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Acutus Medical Inc’s current trading price is -85.17% away from its 52-week high, while its distance from the 52-week low is 1.00%. The stock’s price range for this period has been between $0.16 and $1.09. The Healthcare sector company’s shares saw a trading volume of about 1.1 million for the day, which was lower than the average daily volume of 2.33 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

Acutus Medical Inc (AFIB) has experienced a quarterly decline of -18.63% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 4.80M and boasts a workforce of 233 employees.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.2051, with a change in price of -0.3067. Similarly, Acutus Medical Inc recorded 1,804,253 in trading volume during the last 100 days, posting a change of -65.49%.

AFIB’s Debt-to-Equity Ratio: A Comprehensive Review

A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for AFIB stands at 1.23. Similarly, the long-term debt-to-equity ratio is also 1.21.

AFIB Stock Stochastic Average

As of today, the raw stochastic average of Acutus Medical Inc over the last 50 days is at 0.00%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 0.00%. Further, the company’s Stochastic %K and %D values for the last 20 days were 7.56% and 8.28%, respectively.